Berenberg Bank set a €89.95 ($104.59) price objective on Fresenius Medical Care AG & Co. KGaA (ETR:FME) in a research note released on Friday morning, Borsen Zeitung reports. The firm currently has a buy rating on the stock.

Other equities research analysts have also recently issued reports about the stock. JPMorgan Chase & Co. dropped their price target on shares of Boeing from $430.00 to $425.00 and set an overweight rating for the company in a research report on Thursday, July 25th. Morgan Stanley lifted their price target on shares of WPP from GBX 1,025 ($13.39) to GBX 1,060 ($13.85) and gave the company an equal weight rating in a research report on Wednesday, July 17th. Credit Suisse Group reiterated a buy rating and set a $90.00 price target on shares of Bayerische Motoren Werke in a research report on Thursday, July 18th. Barclays set a €81.00 ($94.19) price target on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a buy rating in a research report on Thursday, July 18th. Finally, Kepler Capital Markets set a €80.00 ($93.02) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a buy rating in a research note on Thursday, May 2nd. Seven research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. Fresenius Medical Care AG & Co. KGaA presently has a consensus rating of Buy and a consensus price target of €82.57 ($96.01).

Shares of FME opened at €67.40 ($78.37) on Friday. Fresenius Medical Care AG & Co. KGaA has a 1-year low of €55.44 ($64.47) and a 1-year high of €91.74 ($106.67). The firm has a market capitalization of $20.58 billion and a PE ratio of 10.50. The company’s 50-day moving average is €68.71. The company has a current ratio of 1.02, a quick ratio of 0.67 and a debt-to-equity ratio of 100.05.

Fresenius Medical Care AG & Co. KGaA Company Profile

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services in Germany, the United States, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.

Featured Article: What is the Quick Ratio?

Analyst Recommendations for Fresenius Medical Care AG & Co. KGaA (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.